GlassScriptPhysician profile
Dena Pelletreau
NPI 1083177489
$8,813.64
in general payments reported to CMS, 2019-2025
25 companies · $3,500 in 2025
The $3,500 reported for 2025 was more than what 98% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $373 · 2022: $2,233 · 2023: $940 · 2024: $1,767 · 2025: $3,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,379 · Travel and Lodging: $2,827 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,379.26 |
| Travel and Lodging | $2,827.25 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,534.77 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $2,003.10 | 2021-2025 | Symplicity G3, Corevalve Evolut R |
| Penumbra, INC. | $934.54 | 2024-2025 | Indigo System |
| Boston Scientific Corporation | $529.16 | 2022-2025 | Watchman Access System, General - Therapies |
| Pfizer INC. | $339.80 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $235.04 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $215.84 | 2021-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $130.05 | 2023-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $125.50 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $79.66 | 2023-2024 | Brilinta, Wainua, Andexxa |
| E.R. Squibb & Sons, L.L.C. | $79.50 | 2022-2024 | Camzyos, Eliquis |
| Shockwave Medical, INC | $67.57 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $67.27 | 2024-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals International, Plc | $60.83 | 2024 | Arcalyst |
| Chiesi USA, INC. | $59.41 | 2023-2025 | Kengreal, Cleviprex |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $52.04 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.63 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $44.45 | 2025 | |
| Abbott Laboratories | $43.19 | 2025 | Navitor |
| Merck Sharp & Dohme LLC | $36.02 | 2023-2024 | Verquvo |
| Bridgebio Pharma, INC. | $36.00 | 2025 | Attruby |
| Abiomed | $23.56 | 2025 | |
| Lemaitre Vascular, INC. | $21.92 | 2023 | Tyke, Patch, Pledget and Intracardiac |
| Novo Nordisk INC | $21.56 | 2023 | Ozempic, Rybelsus |
| Altathera Pharmaceuticals LLC | $21.23 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dena Pelletreau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.